Outcome of aggressive B-cell lymphoma with TP53 alterations administered with CAR T-cell cocktail alone or in combination with ASCT

по Jia Wei, Min Xiao, Zekai Mao, Na Wang, Yang Cao, Yi Xiao, Fankai Meng, Weimin Sun, Ying Wang, Xingcheng Yang, Liting Chen, Yicheng Zhang, Haichuan Zhu, Shangkun Zhang, Tongcun Zhang, Jianfeng Zhou, Liang Huang
Опубликовано 2022-04-01

Chimeric Antigen Receptor-Modified T Cell Immunotherapy for Relapsed and Refractory Adult Burkitt Lymphoma

по Jiaying Wu, Yang Cao, Qi Zhang, Wanying Liu, Xiaoxi Zhou, Xi Ming, Fankai Meng, Yicheng Zhang, Chunrui Li, Liang Huang, Jia Wei, Miao Zheng, Shangkun Zhang, Tongcun Zhang, Xiaojian Zhu, Na Wang, Jue Wang, Gaoxiang Wang, Jianfeng Zhou, Bo Liu, Yi Xiao
Опубликовано 2022-05-01

T Cell Defects: New Insights Into the Primary Resistance Factor to CD19/CD22 Cocktail CAR T-Cell Immunotherapy in Diffuse Large B-Cell Lymphoma

по Jiachen Wang, Jiachen Wang, Kefeng Shen, Kefeng Shen, Wei Mu, Wei Mu, Weigang Li, Meilan Zhang, Meilan Zhang, Wei Zhang, Wei Zhang, Zhe Li, Zhe Li, Tong Ge, Tong Ge, Zhoujie Zhu, Shangkun Zhang, Caixia Chen, Caixia Chen, Shugang Xing, Shugang Xing, Li Zhu, Li Zhu, Liting Chen, Liting Chen, Na Wang, Na Wang, Liang Huang, Liang Huang, Dengju Li, Dengju Li, Min Xiao, Min Xiao, Jianfeng Zhou, Jianfeng Zhou
Опубликовано 2022-04-01